Skip to main content

In vitro stability of B-type natriuretic peptide (BNP) in plasma stored under different conditions when measured with the Lumipulse<sup>®</sup> assay.

García de Guadiana-Romualdo L, Ramos-Arenas V, Campos-Rodríguez V, Consuegra-Sánchez L, Albaladejo-Otón MD

Publication: Scand J Clin Lab Invest (2019) • Vol 79 • Page 455-458PMID: 31244337View on PubMed

Purpose

This paper investigated the effects of delayed centrifugation, delayed analysis, and frozen storage on the measured levels of B-type natriuretic peptide (BNP) in plasma from healthy patients and those with heart conditions.

Conclusion

BNP levels decreased significantly with post-centrifugation storage at either temperature with changes exceeding the acceptable limit occurring at both temperatures after more than 12 h in specimens from healthy patients and more than 4 h in specimens from acute coronary syndrome patients. BNP concentrations were not affected when blood was stored at room temperature for 4 h before centrifugation or when plasma was stored frozen for up to 3 months, regardless of diagnosis.

Studies (2)

Purpose

This study investigated the effects of delayed centrifugation and delayed analysis on the measured levels of BNP in plasma from healthy patients and those with acute coronary disease. Blood was collected from six healthy patients and five intensive care unit patients with acute coronary syndrome into two EDTA Vacutainer tubes. One tube was immediately centrifuged and BNP levels in plasma were than assayed after 0, 4, 12, 24, 48, and 72 h of storage at room temperature or 4°C. The other tube was stored for 4 h before centrifugation at 3500 rpm for 10 min and then BNP levels were assayed immediately. BNP was assayed using a chemiluminescence immunoassay on a LUMIPULSE 600II G analyzer.

Summary of Findings

BNP levels decreased significantly with post-centrifugation storage at either temperature. During room temperature storage, the percent deviation exceeded the acceptable limit (4.8% for healthy patients and 4.1% for acute coronary syndrome patients) when specimens from healthy patients were stored for more than 12 h or specimens from acute coronary syndrome patients were stored for more than 4 h. During refrigerated storage, the percent deviation exceeded the acceptable limit when specimens from healthy patients were stored for more than 12 h or specimens from acute coronary syndrome patients were stored for more than 4 h.  BNP concentrations were stable when blood from either group was stored at room temperature for 4 h before centrifugation.

  • Biospecimens

    FluidBlood
    FluidPlasma
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Coronary Artery Disease
    Normal
  • Platforms

    PeptideClinical chemistry/auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Acute coronary syndrome
    Healthy
    Biospecimen Aliquots and ComponentsCentrifugation
    Centrifugation delays investigated
    StorageStorage duration
    0 h
    12 h
    24 h
    4 h
    48 h
    72 h
    StorageStorage temperature
    4°C
    Room temperature
    StorageTime at room temperature
    0 h
    4 h